In addition, rapamycin, which works as an autophagic activator, strongly decreased the pathogenic TDP-43 species and attenuated TDP-43-induced neurotoxicity in ALS and FTD models (Cheng et al., 2015; Lattante et al., 2015). This evidence concerns the gene TARDBP and frontotemporal dementia.